Compile Data Set for Download or QSAR
Report error Found 80 Enz. Inhib. hit(s) with Target = 'Tau-tubulin kinase 2'
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50609151(CHEMBL5283456)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of TTBK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50609159(CHEMBL5280210)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of TTBK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602886(CHEMBL5182036)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of TTBK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50609146(CHEMBL5273263)
Affinity DataIC50: 13nMAssay Description:Inhibition of TTBK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50506660(CHEMBL4528881)
Affinity DataIC50: 170nMAssay Description:Inhibition of TTBK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602885(CHEMBL5193906)
Affinity DataIC50: 170nMAssay Description:Inhibition of TTBK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602917(CHEMBL5200069 | US20250051335, Compound 14)
Affinity DataIC50: 490nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602917(CHEMBL5200069 | US20250051335, Compound 14)
Affinity DataIC50: 490nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602903(CHEMBL5198544 | US20250051335, Compound 1)
Affinity DataIC50: 850nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602903(CHEMBL5198544 | US20250051335, Compound 1)
Affinity DataIC50: 850nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602907(CHEMBL5193488 | US20250051335, Compound 5)
Affinity DataIC50: 970nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602907(CHEMBL5193488 | US20250051335, Compound 5)
Affinity DataIC50: 970nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602909(CHEMBL5197789 | US20250051335, Compound 7)
Affinity DataIC50: 1.21E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602909(CHEMBL5197789 | US20250051335, Compound 7)
Affinity DataIC50: 1.21E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602926(CHEMBL5200160 | US11814388, Compound 9 | US2025005...)
Affinity DataIC50: 1.21E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602926(CHEMBL5200160 | US11814388, Compound 9 | US2025005...)
Affinity DataIC50: 1.21E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602910(CHEMBL5209196 | US20250051335, Compound 8)
Affinity DataIC50: 1.24E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602910(CHEMBL5209196 | US20250051335, Compound 8)
Affinity DataIC50: 1.24E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602900(CHEMBL5185704 | US11814388, Compound 3)
Affinity DataIC50: 1.32E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602899(CHEMBL5207783)
Affinity DataIC50: 1.68E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602933(CHEMBL5178462)
Affinity DataIC50: 1.75E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602931(CHEMBL5197012)
Affinity DataIC50: 2.03E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602906(CHEMBL5187459 | US20250051335, Compound 4)
Affinity DataIC50: 2.14E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602906(CHEMBL5187459 | US20250051335, Compound 4)
Affinity DataIC50: 2.14E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602932(CHEMBL5178965)
Affinity DataIC50: 2.61E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602920(CHEMBL5187125 | US20250051335, Compound 20)
Affinity DataIC50: 2.70E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602920(CHEMBL5187125 | US20250051335, Compound 20)
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602930(CHEMBL5181249)
Affinity DataIC50: 2.75E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602929(CHEMBL5193034)
Affinity DataIC50: 2.87E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602905(CHEMBL5208565 | US20250051335, Compound 3)
Affinity DataIC50: 3.02E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602905(CHEMBL5208565 | US20250051335, Compound 3)
Affinity DataIC50: 3.02E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602922(CHEMBL5184336 | US20250051335, Compound 21)
Affinity DataIC50: 3.05E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602922(CHEMBL5184336 | US20250051335, Compound 21)
Affinity DataIC50: 3.05E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602923(CHEMBL5178871 | US20250051335, Compound 19)
Affinity DataIC50: 3.90E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602923(CHEMBL5178871 | US20250051335, Compound 19)
Affinity DataIC50: 3.90E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50506661(CHEMBL4517951)
Affinity DataIC50: 4.20E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602904(CHEMBL5204869 | US20250051335, Compound 2)
Affinity DataIC50: 4.22E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602904(CHEMBL5204869 | US20250051335, Compound 2)
Affinity DataIC50: 4.22E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602921(CHEMBL5180098 | US20250051335, Compound 18)
Affinity DataIC50: 4.49E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602921(CHEMBL5180098 | US20250051335, Compound 18)
Affinity DataIC50: 4.49E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602911(CHEMBL5171328 | US20250051335, Compound 9)
Affinity DataIC50: 4.90E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602911(CHEMBL5171328 | US20250051335, Compound 9)
Affinity DataIC50: 4.90E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602925(CHEMBL5188513 | US20250051335, Compound 23)
Affinity DataIC50: 4.94E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602925(CHEMBL5188513 | US20250051335, Compound 23)
Affinity DataIC50: 4.94E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602928(CHEMBL5209161 | US20250051335, Compound 26)
Affinity DataIC50: 5.40E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602928(CHEMBL5209161 | US20250051335, Compound 26)
Affinity DataIC50: 5.40E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602898(CHEMBL5171736)
Affinity DataIC50: 5.70E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM720563(US20250051335, Compound 16)
Affinity DataIC50: 5.72E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602919(CHEMBL5169390)
Affinity DataIC50: 5.72E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTau-tubulin kinase 2(Human)
Biogen

Curated by ChEMBL
LigandPNGBDBM50602934(CHEMBL5206548)
Affinity DataIC50: 6.05E+3nMAssay Description:Inhibition of recombinant human TTBK2 using RICDLHDDEEDEAMSITA as substrate incubated for 30 mins in presence of 33P-gamma-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
Displayed 1 to 50 (of 80 total ) | Next | Last >>
Jump to: